MYCELX Technologies Corporation (LSE:MYX) — Stock Price
MYCELX Technologies Corporation (LSE:MYX) is currently trading at GBX49.00 GBX, up 0.00% today. Over the past 52 weeks, shares have ranged between GBX23.00 and GBX66.50. This page tracks MYCELX Technologies Corporation's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see MYX company net worth.
MYCELX Technologies Corporation (MYX) Stock Price Chart — Daily History & Trading Volume
The chart below tracks MYCELX Technologies Corporation's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
MYCELX Technologies Corporation Income Statement — Revenue, Profit & Earnings by Year
MYCELX Technologies Corporation's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | GBX4.90 Million | GBX10.91 Million | GBX10.03 Million | GBX8.48 Million | GBX7.10 Million |
| Cost of Revenue | GBX3.56 Million | GBX7.02 Million | GBX5.58 Million | GBX5.20 Million | GBX5.51 Million |
| Gross Profit | GBX1.34 Million | GBX3.89 Million | GBX4.44 Million | GBX3.27 Million | GBX1.59 Million |
| Research & Development | GBX219.00K | GBX248.00K | GBX218.00K | GBX223.00K | GBX64.00K |
| SG&A | GBX5.43 Million | GBX6.73 Million | GBX7.59 Million | GBX6.94 Million | GBX7.27 Million |
| Total Operating Expenses | GBX5.90 Million | GBX7.22 Million | GBX8.02 Million | GBX7.37 Million | GBX7.64 Million |
| Operating Income | GBX-4.55 Million | GBX-3.33 Million | GBX-3.58 Million | GBX-1.51 Million | GBX-6.05 Million |
| EBITDA | GBX-2.23 Million | GBX-2.46 Million | GBX-2.48 Million | GBX19.00K | GBX-4.22 Million |
| EBIT | GBX-2.62 Million | GBX-3.33 Million | GBX-3.57 Million | GBX-1.10 Million | GBX-5.65 Million |
| Interest Expense | GBX13.00K | GBX9.00K | GBX2.00K | GBX24.00K | GBX117.00K |
| Income Before Tax | GBX-2.64 Million | GBX-3.34 Million | GBX-3.57 Million | GBX-1.13 Million | GBX-5.77 Million |
| Income Tax Expense | GBX85.00K | GBX365.00K | GBX418.00K | GBX296.00K | GBX328.00K |
| Net Income | GBX-2.72 Million | GBX-3.71 Million | GBX-3.99 Million | GBX-1.43 Million | GBX-6.09 Million |
MYCELX Technologies Corporation Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes MYCELX Technologies Corporation's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | GBX10.05 Million | GBX10.39 Million | GBX13.62 Million | GBX15.66 Million | GBX19.13 Million |
| Total Current Assets | GBX7.18 Million | GBX6.19 Million | GBX8.48 Million | GBX10.18 Million | GBX11.10 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | GBX1.76 Million | GBX2.07 Million | GBX2.78 Million | GBX2.04 Million | GBX1.48 Million |
| Inventory | GBX4.00 Million | GBX3.42 Million | GBX3.74 Million | GBX4.32 Million | GBX5.64 Million |
| Property, Plant & Equipment | — | — | — | GBX4.71 Million | GBX7.24 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | GBX4.79 Million | GBX3.23 Million | GBX2.79 Million | GBX3.04 Million | GBX5.34 Million |
| Total Current Liabilities | GBX3.91 Million | GBX2.63 Million | GBX1.90 Million | GBX1.82 Million | GBX3.52 Million |
| Long-term Debt | — | — | — | GBX0.00 | GBX1.54 Million |
| Net Debt | GBX-3.00K | GBX506.00K | GBX-429.00K | GBX-1.66 Million | GBX-202.00K |
| Total Stockholder Equity | GBX5.26 Million | GBX7.16 Million | GBX10.83 Million | GBX12.62 Million | GBX13.79 Million |
| Retained Earnings | GBX-40.94 Million | GBX-38.22 Million | GBX-34.51 Million | GBX-30.52 Million | GBX-29.09 Million |
MYCELX Technologies Corporation Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how MYCELX Technologies Corporation generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | GBX-2.15 Million | GBX-1.11 Million | GBX-2.69 Million | GBX-3.43 Million | GBX-1.50 Million |
| Capital Expenditures | GBX45.00K | GBX90.00K | GBX842.00K | GBX370.00K | GBX159.00K |
| Free Cash Flow | GBX-2.20 Million | GBX-1.21 Million | GBX-3.53 Million | GBX-3.80 Million | GBX-1.66 Million |
| Investing Cash Flow | GBX2.24 Million | GBX-181.00K | GBX-842.00K | GBX5.08 Million | GBX-159.00K |
| Financing Cash Flow | GBX792.00K | — | GBX2.04 Million | GBX-2.24 Million | GBX1.30 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | GBX37.00K | GBX31.00K | GBX156.00K | GBX255.00K | GBX42.00K |
| Depreciation | GBX398.00K | GBX868.00K | GBX1.09 Million | GBX1.12 Million | GBX1.43 Million |
| Change in Cash | GBX877.00K | GBX-1.30 Million | GBX-1.48 Million | GBX-580.00K | GBX-355.00K |
MYCELX Technologies Corporation Earnings History — EPS Actual vs. Analyst Estimates
Track MYCELX Technologies Corporation's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | — | — | — |
| Sep 22, 2025 | — | — | — |
| May 12, 2025 | — | — | — |